Interleukin-13 Antagonist [EPC] - N0000193985

Pharmacologic Code	N0000193985
Pharmacologic Name	Interleukin-13 Antagonist
Pharmacologic Uses	interleukin-13 antagonist
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 4 products whose active ingredient are classified under the same pharmacologic class Interleukin-13 Antagonist [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0002-7772	Ebglyss	Non-Proprietary Name: Lebrikizumab-lbkz	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
	0002-7797	Ebglyss	Non-Proprietary Name: Lebrikizumab-lbkz	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
	50222-346	Adbry	Non-Proprietary Name: Tralokinumab-ldrm	Injection, Solution	Subcutaneous	Leo Pharma Inc.	ACTIVE
	50222-350	Adbry	Non-Proprietary Name: Tralokinumab-ldrm	Injection, Solution	Subcutaneous	Leo Pharma Inc.	ACTIVE